Generic EpiPen Coming For $300 As Mylan Responds To Outrage

Responding to national outrage over high prices, Mylan announced plans on Monday to launch a generic EpiPen at a 50% discount to the branded version of the life saving allergy treatment.

The generic EpiPen will be “identical” to the branded product in terms of how the drug is made and how the auto-injector functions, Mylan (MYL) said.

 The surprise move is the latest attempt by Mylan to silence the uproar ignited by a more than 400% increase in EpiPen prices. The launch comes ahead of looming competition from Teva Pharmaceuticals (TEVA), which is hoping to launch a generic EpiPen of its own as early as next year, pending FDA approval.

Mylan said it plans to launch the generic version in “several weeks” at a cost of $300 per two-pack carton, compared with $608 for the branded EpiPen.

Mylan didn’t specify what discounts — if any — it is offering on this $300 generic price. It’s also not clear why consumers would buy the more expensive branded EpiPen if, as Mylan describes it, it’s exactly the same as the generic.

The company didn’t respond to a request for comment.